Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection

There is evidence indicating that invariant Natural Killer T (iNKT) cells play an important role in defense against influenza A virus (IAV). However, the effect of inhibitory receptor, programmed death-1 (PD-1), and its ligands, programmed death ligand (PD-L) 1 and 2 on iNKT cells in protection against IAV remains to be elucidated. Here we investigated the effects of these co-stimulatory molecules on iNKT cells in the response to influenza. We discovered that compare to the wild type, PD-L1 deficient mice show reduced sensitivity to IAV infection as evident by reduced weight loss, decreased pulmonary inflammation and cellular infiltration. In contrast, PD-L2 deficient mice showed augmented weight loss, pulmonary inflammation and cellular infiltration compare to the wild type mice after influenza infection. Adoptive transfer of iNKT cells from wild type, PD-L1 or PD-L2 deficient mice into iNKT cell deficient mice recapitulated these findings. Interestingly, in our transfer system PD-L1−/−-derived iNKT cells produced high levels of interferon-gamma whereas PD-L2−/−-derived iNKT cells produced high amounts of interleukin-4 and 13 suggesting a role for these cytokines in sensitivity to influenza. We identified that PD-L1 negatively regulates the frequency of iNKT cell subsets in the lungs of IAV infected mice. Altogether, these results demonstrate that lack of PD-L1 expression by iNKT cells reduces the sensitivity to IAV and that the presence of PD-L2 is important for dampening the deleterious inflammatory responses after IAV infection. Our findings potentially have clinical implications for developing new therapies for influenza.

[1]  Anneliese O. Speak,et al.  Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. , 2013, The Journal of allergy and clinical immunology.

[2]  Annette S. Kim,et al.  Viral acute lower respiratory infections impair CD8+ T cells through PD-1. , 2012, The Journal of clinical investigation.

[3]  G. Freeman,et al.  The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo , 2011, The Journal of Immunology.

[4]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[5]  M. Si-Tahar,et al.  Potential Role of Invariant NKT Cells in the Control of Pulmonary Inflammation and CD8+ T Cell Response during Acute Influenza A Virus H3N2 Pneumonia , 2011, The Journal of Immunology.

[6]  C. Stempin,et al.  Programmed death ligand 2 regulates arginase induction and modifies Trypanosoma cruzi survival in macrophages during murine experimental infection , 2011, Immunology.

[7]  C. Boitard,et al.  Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay , 2011, The Journal of experimental medicine.

[8]  P. Stock,et al.  Role of PD‐L1 and PD‐L2 in allergic diseases and asthma , 2011, Allergy.

[9]  Taeg S. Kim,et al.  Antiviral CD8+ T cell effector activities in situ are regulated by target cell type , 2011, The Journal of experimental medicine.

[10]  S. Akira,et al.  Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. , 2011, The Journal of clinical investigation.

[11]  Michael G. Katze,et al.  Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice , 2010, PLoS pathogens.

[12]  J. Allison,et al.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors , 2010, Proceedings of the National Academy of Sciences.

[13]  Nathan E. Hnatiuk,et al.  A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity , 2010, The Journal of Immunology.

[14]  C. Paget,et al.  NKT cell immune responses to viral infection , 2009, Expert opinion on therapeutic targets.

[15]  S. Stevanović,et al.  Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. , 2008, Vaccine.

[16]  Anneliese O. Speak,et al.  Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. , 2008, The Journal of clinical investigation.

[17]  M. Smyth,et al.  Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4−NK1.1− NKT cell population , 2008, Proceedings of the National Academy of Sciences.

[18]  A. McMichael,et al.  Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection , 2008, European journal of immunology.

[19]  S. Matsushita,et al.  Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells , 2008, European journal of immunology.

[20]  Michael B. Brenner,et al.  CD1 antigen presentation: how it works , 2007, Nature Reviews Immunology.

[21]  J. Berzofsky,et al.  NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis. , 2007, Trends in immunology.

[22]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[23]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[24]  W. Thompson,et al.  Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. , 2006, The Journal of infectious diseases.

[25]  Yongliang Zhang,et al.  Regulation of T cell activation and tolerance by PDL2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Freeman,et al.  Tissue expression of PD-L1 mediates peripheral T cell tolerance , 2006, The Journal of experimental medicine.

[27]  K. Wood,et al.  Interferon γ: a crucial role in the function of induced regulatory T cells in vivo , 2006 .

[28]  G. Freeman,et al.  PD‐L1 and PD‐L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis , 2006, European journal of immunology.

[29]  S. Khoury,et al.  A critical role for the programmed death ligand 1 in fetomaternal tolerance , 2005, The Journal of experimental medicine.

[30]  T. Braciale,et al.  Frequency, Specificity, and Sites of Expansion of CD8+ T Cells during Primary Pulmonary Influenza Virus Infection1 , 2005, The Journal of Immunology.

[31]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[32]  N. Afdhal,et al.  Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.

[33]  G. Freeman,et al.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Paul,et al.  Interferon γ Enhances Both In Vitro and In Vivo Priming of CD4+ T Cells for IL-4 Production , 2004, The Journal of experimental medicine.

[35]  M. Degli-Esposti,et al.  NKT cells and viral immunity , 2004, Immunology and cell biology.

[36]  D. Pardoll,et al.  References Subscriptions Permissions Email Alerts B7-DC Regulates Asthmatic Response by an IFN- γ-Dependent Mechanism , 2013 .

[37]  G. Freeman,et al.  Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.

[38]  A. Ashkar,et al.  Interleukin-15 and Natural Killer and NKT Cells Play a Critical Role in Innate Protection against Genital Herpes Simplex Virus Type 2 Infection , 2003, Journal of Virology.

[39]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[40]  D. Pardoll,et al.  Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 , 2002, The Journal of Immunology.

[41]  T. Strom,et al.  Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. , 2002, The Journal of clinical investigation.

[42]  B. Graham,et al.  NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus , 2002, Journal of Virology.

[43]  G. Freeman,et al.  Expression and Regulation of the PD‐L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells , 2002, Microcirculation.

[44]  D. Haas,et al.  CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection , 2002, The Journal of experimental medicine.

[45]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[46]  F. Chisari,et al.  Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.

[47]  A. García-Sastre,et al.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Zhu,et al.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion , 1999, Nature Medicine.

[49]  A. García-Sastre,et al.  The Role of Interferon in Influenza Virus Tissue Tropism , 1998, Journal of Virology.

[50]  M Kurimoto,et al.  Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. , 1998, Journal of immunology.

[51]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[52]  P. Keskinen,et al.  Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. , 1997, Journal of immunology.

[53]  A. Fernández-Sesma,et al.  Interleukin-4 causes delayed virus clearance in influenza virus-infected mice , 1996, Journal of virology.

[54]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[55]  B. Murphy,et al.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine , 1986, Journal of clinical microbiology.

[56]  J. Mullooly,et al.  Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.

[57]  D. Richman,et al.  Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). , 1975, Virology.

[58]  R. Chanock,et al.  Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. , 1973, The Journal of infectious diseases.

[59]  G. Freeman,et al.  PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions , 2010, Mucosal Immunology.

[60]  V. Cerundolo,et al.  Harnessing invariant NKT cells in vaccination strategies , 2009, Nature Reviews Immunology.

[61]  G. Freeman,et al.  PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8 T Lymphocytes in the Liver , 2007 .

[62]  K. Wood,et al.  Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. , 2006, Trends in immunology.

[63]  D. Pardoll,et al.  B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. , 2004, Journal of immunology.

[64]  G. Mayrhofer,et al.  Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. , 2003, Journal of immunology.

[65]  M. Taniguchi,et al.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.

[66]  J. Mullooly,et al.  Pneumonia and influenza deaths during epidemics: implications for prevention. , 1982, Archives of internal medicine.